Entera Bio Ltd. - Ordinary Shares (ENTX) earnings
ENTX earnings moved a median of -1.47% by the close. Quarterly and annual ENTX reports and results, each read against the price at its own news timestamp. Back to the ENTX overview →
17 measured ENTX earnings events.
Where these ENTX earnings landedvs 15 measured ENTX earnings reactions
| Middle 50% of ENTX earnings reactions | -4.16% to +0.83% |
|---|---|
| Median reaction (to close) | -1.47% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 ENTX earnings events with a measured close landed between -4.16% and +0.83%; 27% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Entera Announces Second Quarter 2026 Financial Results and Business Updates | Press release | -1.76% | — | |
| Form 10-Q Entera Bio Ltd. For: Jun 30 | SEC filing · Form 10-Q | -1.76% | — | |
| Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs | Press release | -1.60% | -6.40% | |
| Form 10-Q Entera Bio Ltd. For: Mar 31 | SEC filing · Form 10-Q | -1.60% | -6.40% | |
| Form 10-K Entera Bio Ltd. For: Dec 31 | SEC filing · Form 10-K | +3.55% | -1.96% | |
| Entera Bio Announces Third Quarter 2025 Financial Results and Business Updates | Press release | +0.00% | -1.47% | |
| Form 10-Q Entera Bio Ltd. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.47% | |
| Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates | Press release | +2.21% | +3.87% | |
| Form 10-Q Entera Bio Ltd. For: Jun 30 | SEC filing · Form 10-Q | +2.21% | +3.87% | |
| Entera Bio Announces First Quarter 2025 Financial Results and Business Updates | Press release | — | -1.38% | |
| Form 10-Q Entera Bio Ltd. For: Mar 31 | SEC filing · Form 10-Q | — | -1.38% | |
| Form 10-K Entera Bio Ltd. For: Dec 31 | SEC filing · Form 10-K | — | -2.30% | |
| Form 10-Q Entera Bio Ltd. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.16% | |
| Form 10-Q Entera Bio Ltd. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -6.02% | |
| Form 10-Q Entera Bio Ltd. For: Mar 31 | SEC filing · Form 10-Q | -4.38% | -6.77% | |
| Form 10-K Entera Bio Ltd. For: Dec 31 | SEC filing · Form 10-K | +2.11% | +2.82% | |
| Form 10-Q Entera Bio Ltd. For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.86% |
Keep exploring
More ENTX: analyst actions → · SEC filings → · ENTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | 218 | +0.33% | 54% |
| Anixa Biosciences, Inc. (ANIX) | 217 | 0.00% | 49% |
| Precipio, Inc. (PRPO) | 217 | +0.51% | 52% |
| Sensus Healthcare, Inc. (SRTS) | 217 | 0.00% | 49% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.